G3P2A0 26 Weeks Pregnant Woman with Second Trimester Bleeding e.c Partial Hydatidiform Mole
DOI:
https://doi.org/10.53089/medula.v12i4.524Keywords:
Hydatidiform mole, Hemorrhage, β-hCGAbstract
Hydatidiform mole is an abnormal condition in pregnancy with part or all of the chorionic villi undergo hydropic degeneration. Hydatidiform mole is divided into complete hydatidiform mole and partial hydatidiform mole. The incidence rate in Indonesia is around 1:80 normal deliveries. While the incidence of partial moles is rare, the incidence varies from 5:100,000 and 1:10,000 pregnancies. Mrs. A 37 years old came to the ER Abdul Moeloek Hospital with complained abdominal pain and vaginal bleeding. Result of general examination: moderate ill appearance, blood pressure was 148/89 mmHg, other sign examination were within normal limits. On obstetric examination, the uterine fundal height was two fingers above the umbilicus, the fetal heart rate was 155x/min and three contractions in 10 minutes, the duration was 20-40 seconds. Speculum examination result : opened portio, there is a fish eyed-like bubble, and active bleeding. Ultrasound examination revealed that she was pregnant 26 weeks with a partial hydatidiform mole. Complete blood count with severe anemia. Whereas immunological and serological examinations results: β-hCG 5,242,880 mIU/mL; T3 1.93 nmol/L; T4 157, 43 nmol/L; TSH 0.01 uIU/mL. So the diagnosis is G3P2A0 26 weeks of gestational age in active phase with a partial hydatidiform mole accompanied by hyperthyroidism and severe anemia with single live fetus intrauterine. Patient lead to spontaneous vaginal delivery were then treated with curettage, transfusion and postpartum care. Furthermore, the mole tissue was taken for Anatomical Pathology examination and the patient was planned to control for the β-hCG evaluation.
References
Hadijanto B. Mola Hidatidosa. Dalam : Prawirohardjo, Sarwono. Ilmu Kebidanan. Jakarta: PT. Bina Pustaka Sarwono Prawirohardjo; 2016.
Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Gilstrap LC, Wenstrom KD. Williams Obstetrics. Edisi ke-25. New York: McGraw-Hill; 2018.
ATA, Hyperthyroidism in Patients with Gestational Trophoblastic Disease (GTD) [internet]. Alexandria: American Thyroid Association; 2023 [disitasi tanggal 19 Januari 2023]. Tersedia dari:https://www.thyroid.org/documents/ctfp/volume4/issue9/ct_patients_v49_5.pdf
Tidy J, Hancock BW. The Management of Gestational Trophoblastic Disease. England: Royal College of Obstetricians and Gynaecologists; 2010 [disitasi tanggal 19 Januari 2023]. Tersedia dari:http://www.jsog.org/GuideLines/The_management_of_gestational_trophoblastic_disease.pdf
Altieri A, Franceschi S, Ferlay J, Smith J, Vecchia CL. Epidemiology and aetiology of gestational trophoblastic disease. Lancet Oncol. 2003;4(11):670-8.
Franciscis PD, Schiattarella A, Labriola D, Tammaro C, Messalli EM, Mantia EL, Montella M, Torella M. A Partial molar pregnancy associated with a fetus with intrauterine growth restriction delivered at 31 weeks: a case report. Journal of Medical Case Reports. 2019; 13(1):204.
McGrath S, Short D, Harvey R, Schmid P, Savage PM, Seckl MJ. The management and outcome of women with post-hydatidiform mole ‘low-risk’ gestational trophoblastic neoplasia, but hCG levels in excess of 100 000 IU I-1. British Journal of Cancer. 2010; 102(5):810-814.
Ghassemzadeh S, Farci F, Kang M. Hydatidiform Mole [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 [diperbarui tanggal 23 May 2022]. Tersedia dari: https://www.ncbi.nlm.nih.gov/books/NBK459155/
Malgorzata GC. Thyrotoxicosis and pregnancy. Thyroid Research. 2013;6(Suppl 2)A18.
Labadzhyan A, Brent GA, Hershman JM, Leung AM. Thyrotoxicosis of Pregnancy. J Clin Transl Endocrinol. 2014;1(4):140-144.
Walkington L, Webster J, Hancock BW, Everard J, dan Coleman RE. Hyperthyroidism and Human Chorionic Gonadotrophin Production in Gestational Trophoblastic Disease. British Journal of Cancer. 2011;104(11): 1665-1669.
Irwinda R, Sungkar A, Wibowo N, Krisnadi SR, Joserizal S, Yusrawati, Dkk editor. Panduan Persalinan Preterm. Jakarta : Pengurus Pusat Perkumpulan Obstetri dan Ginekologi Indonesia; 2019.
Yoshihara A, Noh JY, Yamaguchi T, Ohye H, Sato S, Sekiya K, Dkk. Treatment of graves’ disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation. The Journal of Clinical Endocrinology and Metabolism. 2012;97(7)2396-403.
Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, dkk. American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid. 2016;(10):1343-1421.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Medical Profession Journal of Lampung
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.